165 research outputs found

    Importance of extracolonic findings at IV contrast medium-enhanced CT colonography versus those at non-enhanced CT colonography

    Get PDF
    To compare the clinical importance of extracolonic findings at intravenous (IV) contrast-enhanced CT colonography versus those at non-enhanced CT colonography. IV contrast medium-enhanced (n=72) and non-enhanced (n=30) multidetector CT colonography was performed in 102 symptomatic patients followed by conventional colonoscopy on the same day. The impact of extracolonic findings on further work up and treatment was assessed by a review of patient records. Extracolonic findings were divided into two groups: either leading to further work up respectively having an impact on therapy or not. A total of 303 extracolonic findings were detected. Of those, 71% (215/303) were found on IV contrast-enhanced CT, and 29% (88/303) were found on non-enhanced CT colonography. The extracolonic findings in 25% (26/102) of all patients led to further work up or had an impact on therapy. Twenty-two of these patients underwent CT colonography with IV contrast enhancement, and four without. The percentage of extracolonic findings leading to further work up or having an impact on therapy was higher for IV contrast-enhanced (31%; 22/72) than for non-enhanced (13%; 4/30) CT scans (P=0.12). IV contrast-enhanced CT colonography produced more extracolonic findings than non-enhanced CT colonography. A substantially greater proportion of findings on IV contrast-enhanced CT colonography led to further work up and treatment than did non-enhanced CT colonograph

    Effect of Naloxone-3-Glucuronide and N -Methylnaloxone on the Motility of the Isolated Rat Colon After Morphine

    Get PDF
    The effect of the opioid antagonists naloxone-3-glucuronide and N-methylnaloxone on rat colon motility after morphine stimulation was measured. The rat model consisted of the isolated, vascularly perfused colon. The antagonists (10−4 M, intraluminally) and morphine (10−4 M, intra-arterially) were administered from 20 to 30 and from 10 to 50 min, respectively. Colon motility was determined by the luminal outflow. The antagonist concentrations in the luminal and venous outflow were measured by high-performance liquid chromatography. Naloxone-3-glucuronide and N-methylnaloxone reversed the morphine-induced reduction of the luminal outflow to baseline within 10 and 20 min, respectively. These antagonists were then excreted in the luminal outflow and could not be found in the venous samples. Naloxone, produced by hydrolysis or demethylation, was not detectable. In conclusion, highly polar naloxone derivatives peripherally antagonize the motility-lowering effect of morphine in the perfused isolated rat colon, are stable, and are not able to cross the colon-mucosal blood barrie

    Functional Integration of Subcomponents for Hybridization of Fused Filament Fabrication

    Get PDF
    One of the main advantages of additive manufacturing by Fused Filament Fabrication is its wide variety of materials and cost-effective production systems. However, the resolution and tightness of the produced structures are limited. The following article describes a novel approach of the functional integration of stereolithographic produced subcomponents into the Fused Filament Fabrication process and the challenges during integration in terms of adhesion, taking into account different surface pretreatments. Furthermore, it is investigated how conductive polymer composites could be used successfully for conducting mechatronic subcomponents automatically. With the help of these investigations it is aimed to extend the field of application of additive manufactured plastic components

    X-ray Properties of the Weak Seyfert 1 Nucleus in NGC 4639

    Get PDF
    We obtained observations of NGC 4639 with ASCA in order to investigate its mildly active Seyfert 1 nucleus at hard X-ray energies. Koratkar et al. (1995) have previously shown that the nucleus is a pointlike source in the ROSAT soft X-ray band. We detected in the 2-10 keV band a compact central source with a luminosity of 8.3E+40 erg/s. Comparison of the ASCA data with archival data taken with the Einstein and ROSAT satellites shows that the nucleus varies on timescales of months to years. The variability could be intrinsic, or it could be caused by variable absorption. More rapid variability, on a timescale of \~10^4 s, may be present in the ASCA data. The spectrum from 0.5 to 10 keV is well described by a model consisting of a lightly absorbed (N_H = 7.3E+20 cm^-2) power law with a photon index of 1.68. We find no evidence for significant emission from a thermal plasma; if present, it can account for no more than 25% of the flux in the 0.5-2.0 keV band. The limited photon statistics of our data do not allow us to place significant limits on the presence of iron K emission. (abridged)Comment: To appear in The Astrophysical Journal. LaTex, 18 pages including embedded figures and table

    Inhibition of Amyloid-β Aggregation and Caspase-3 Activation by the \u3ci\u3eGinkgo biloba\u3c/i\u3e Extract EGb761

    Get PDF
    Standardized extract from the leaves of the Ginkgo biloba tree, labeled EGb761, has been used in clinical trials for its beneficial effects on brain functions, particularly in connection with age-related dementias and Alzheimer\u27s disease (AD). Substantial experimental evidence indicates that EGb761 protects against neuronal damage from a variety of insults, but its cellular and molecular mechanisms remain unknown. Using a neuroblastoma cell line stably expressing an AD-associated double mutation, we report that EGb761 inhibits formation of amyloid-β (Aβ) fibrils, which are the diagnostic, and possibly causative, feature of AD. The decreased Aβ fibrillogenesis in the presence of EGb761 was observed both in the conditioned medium of this Aβ-secreting cell line and in solution in vitro. In the cells, EGb761 significantly attenuated mitochondrion-initiated apoptosis and decreased the activity of caspase 3, a key enzyme in the apoptosis cell-signaling cascade. These results suggest that (i) neuronal damage in AD might be due to two factors: a direct Aβ toxicity and the apoptosis initiated by the mitochondria; and (ii) multiple cellular and molecular neuroprotective mechanisms, including attenuation of apoptosis and direct inhibition of Aβ aggregation, underlie the neuroprotective effects of EGb761

    Supernova PTF12glz: a possible shock breakout driven through an aspherical wind

    Get PDF
    We present visible-light and ultraviolet (UV) observations of the supernova PTF12glz. The SN was discovered and monitored in near-UV and R bands as part of a joint GALEX and Palomar Transient Factory campaign. It is among the most energetic Type IIn supernovae observed to date (~10^51erg). If the radiated energy mainly came from the thermalization of the shock kinetic energy, we show that PTF12glz was surrounded by ~1 solar mass of circumstellar material (CSM) prior to its explosive death. PTF12glz shows a puzzling peculiarity: at early times, while the freely expanding ejecta are presumably masked by the optically thick CSM, the radius of the blackbody that best fits the observations grows at ~8000km/s. Such a velocity is characteristic of fast moving ejecta rather than optically thick CSM. This phase of radial expansion takes place before any spectroscopic signature of expanding ejecta appears in the spectrum and while both the spectroscopic data and the bolometric luminosity seem to indicate that the CSM is optically thick. We propose a geometrical solution to this puzzle, involving an aspherical structure of the CSM around PTF12glz. By modeling radiative diffusion through a slab of CSM, we show that an aspherical geometry of the CSM can result in a growing effective radius. This simple model also allows us to recover the decreasing blackbody temperature of PTF12glz. SLAB-Diffusion, the code we wrote to model the radiative diffusion of photons through a slab of CSM and evaluate the observed radius and temperature, is made available on-line.Comment: Sumbitted to ApJ. Comments are welcom

    Physical activity and brain health in patients with atrial fibrillation

    Get PDF
    Background and purpose: Vascular brain lesions, such as ischemic infarcts, are common among patients with atrial fibrillation (AF) and are associated with impaired cognitive function. The role of physical activity (PA) in the prevalence of brain lesions and cognition in AF has not been investigated. Methods: Patients from the multicenter Swiss‐AF cohort study were included in this cross‐sectional analysis. We assessed regular exercise (RE; at least once weekly) and minutes of weekly PA using a validated questionnaire. We studied associations with ischemic infarcts, white matter hyperintensities, cerebral microbleeds, and brain volume on brain magnetic resonance imaging and with global cognition measured with a cognitive construct (CoCo) score.ResultsAmong 1490 participants (mean age = 72 ± 9 years), 730 (49%) engaged in RE. In adjusted regression analyses, RE was associated with a lower prevalence of ischemic infarcts (odds ratio [OR] = 0.78, 95% confidence interval [CI] = 0.63–0.98, p = 0.03) and of moderate to severe white matter hyperintensities (OR = 0.78, 95% CI = 0.62–0.99, p = 0.04), higher brain volume (β‐coefficient = 10.73, 95% CI = 2.37–19.09, p = 0.01), and higher CoCo score (β‐coefficient = 0.08, 95% CI = 0.03–0.12, p < 0.001). Increasing weekly PA was associated with higher brain volume (β‐coefficient = 1.40, 95% CI = 0.65–2.15, p < 0.001). Conclusions: In AF patients, RE was associated with a lower prevalence of ischemic infarcts and of moderate to severe white matter disease, with larger brain volume, and with better cognitive performance. Prospective studies are needed to investigate whether these associations are causal. Until then, our findings suggest that patients with AF should be encouraged to remain physically active

    Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial Fibrillation.

    Get PDF
    Background Optimizing health-related quality of life (HRQoL) is an important aim of atrial fibrillation (AF) treatment. Little is known about patients' long-term HRQoL trajectories and the impact of patient and disease characteristics. The aim of this study was to describe HRQoL trajectories in an observational AF study population and in clusters of patients with similar patient and disease characteristics. Methods and Results We used 5-year follow-up data from the Swiss-Atrial Fibrillation prospective cohort, which enrolled 2415 patients with prevalent AF from 2014 to 2017. HRQoL data, collected yearly, comprised EuroQoL-5 dimension utilities and EuroQoL visual analog scale scores. Patient clusters with similar characteristics at enrollment were identified using hierarchical clustering. HRQoL trajectories were analyzed descriptively and with inverse probability-weighted regressions. Effects of postbaseline clinical events were additionally assessed using time-shifted event variables. Among 2412 (99.9%) patients with available baseline HRQoL, 3 clusters of patients with AF were identified, which we characterized as follows: "cardiovascular dominated," "isolated symptomatic," and "severely morbid without cardiovascular disease." Utilities and EuroQoL visual analog scale scores remained stable over time for the full population and the clusters; isolated symptomatic patients showed higher levels of HRQoL. Utilities were reduced after occurrences of stroke, hospitalization for heart failure, and bleeding, by -0.12 (95% CI, -0.18 to -0.06), -0.10 (95% CI, -0.13 to -0.08), and -0.06 (95% CI, -0.08 to -0.04), respectively, on a 0 to 1 utility scale. Utility of surviving patients returned to preevent levels 4 years after heart failure hospitalization; 3 years after bleeding; and 1 year after stroke. Conclusions In patients with prevalent AF, HRQoL was stable over time, irrespective of baseline patient characteristics. Clinical events of hospitalization for heart failure, stroke, and bleeding had only a temporary effect on HRQoL

    Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial Fibrillation

    Get PDF
    Background: Optimizing health-related quality of life (HRQoL) is an important aim of atrial fibrillation (AF) treatment. Little is known about patients' long-term HRQoL trajectories and the impact of patient and disease characteristics. The aim of this study was to describe HRQoL trajectories in an observational AF study population and in clusters of patients with similar patient and disease characteristics. Methods and Results: We used 5-year follow-up data from the Swiss-Atrial Fibrillation prospective cohort, which enrolled 2415 patients with prevalent AF from 2014 to 2017. HRQoL data, collected yearly, comprised EuroQoL-5 dimension utilities and EuroQoL visual analog scale scores. Patient clusters with similar characteristics at enrollment were identified using hierarchical clustering. HRQoL trajectories were analyzed descriptively and with inverse probability-weighted regressions. Effects of postbaseline clinical events were additionally assessed using time-shifted event variables. Among 2412 (99.9%) patients with available baseline HRQoL, 3 clusters of patients with AF were identified, which we characterized as follows: "cardiovascular dominated," "isolated symptomatic," and "severely morbid without cardiovascular disease." Utilities and EuroQoL visual analog scale scores remained stable over time for the full population and the clusters; isolated symptomatic patients showed higher levels of HRQoL. Utilities were reduced after occurrences of stroke, hospitalization for heart failure, and bleeding, by -0.12 (95% CI, -0.18 to -0.06), -0.10 (95% CI, -0.13 to -0.08), and -0.06 (95% CI, -0.08 to -0.04), respectively, on a 0 to 1 utility scale. Utility of surviving patients returned to preevent levels 4 years after heart failure hospitalization; 3 years after bleeding; and 1 year after stroke. Conclusions: In patients with prevalent AF, HRQoL was stable over time, irrespective of baseline patient characteristics. Clinical events of hospitalization for heart failure, stroke, and bleeding had only a temporary effect on HRQoL
    corecore